期刊文献+

Calcineurin/NFAT信号通路上调5型磷酸二酯酶的表达及介导内皮素-1诱导的肺动脉平滑肌细胞增殖 被引量:6

Calcineurin/NFAT signaling pathway mediates endothelin-1-induced pulmonary artery smooth muscle cell proliferation by regulating phosphodiesterase-5
下载PDF
导出
摘要 目的探讨Calcineurin/NFAT信号通路是否介导内皮素-1(ET-1)诱导的5型磷酸二酯酶(PDE5)的表达及肺动脉平滑肌细胞(PASMCs)的增殖;同时验证Calcineurin抑制剂环孢素A及PDE5抑制剂西地那非能否抑制ET-1刺激的PASMCs增殖。方法以ET-1刺激PASMCs增殖,分别于ET-1刺激前给予环孢素A或西地那非抑制Calcineurin或PDE5的活性。采用Calcineurin活性检测试剂盒检测其活性,免疫印迹法检测PDE5的表达,酶联免疫吸附法检测cGMP的含量,3H-TdR渗入法检测PASMCs的增殖。结果 ET-1可激活原代培养的PASMCs中Calcineurin的活性,上调PDE5表达,降低cGMP的水平。Calcineurin特异性抑制剂环孢素A可阻断ET-1的上述作用;抑制PDE5的活性可逆转ET-1导致的cGMP含量减少。而环孢素A及西地那非可分别抑制ET-1刺激的PASMCs增殖。结论 ET-1可通过激活Calcineurin/NFAT信号通路介导ET-1诱发的PDE5表达,进而降低cGMP含量,引起PASMCs增殖;而抑制Calcineurin或PDE5可提高cGMP水平,抑制ET-1诱导的PASMCs增殖。 Objective To examine whether calcineurin/NFAT signaling pathway mediates endothelin-1 (ET-1)-induced proliferation of pulmonary artery smooth muscle ceils (PASMCs) by regulating phosphodiesterase-5 (PDE5) and the effect of the selective calcineurin inhibitor cyclosporine A and PDE5 inhibitor sildenafil on ET-l-induced PASMC proliferation. Methods PASMCs were treated with ET-1 to stimulate their proliferation with or without prior treatment of the cells with CsA or sildenafil. Calcineurin activity in the cells was measured using a calcineurin activity assay kit, PDE5 expression examined using immunoblotting, and cGMP level detected using a cGMP direct immunoassay kit. PASMC proliferation following the treatments was determined using [3H]thymidine incorporation assay. Results ET-1 caused a 2.05-fold increase in the cellular calcineurin activity, a 1.80-fold increase in PDE5 expression, and a 3.20-fold increase in the DNA synthesis rate, and reduced the cGMP level by 67%. Pretreatment of the cells with Cycloporine blocked the effects of ET-1, and PDE5 inhibition by sildenafil pretreatment also abolished ET-l-induced reduction of cGMP level in the cells. Both Cycloporine and sildenafil suppressed ET-l-stimulated PASMC proliferation. Conclusion Activation of calcineurin/NFAT signaling pathway mediates ET-l-induced PASMC proliferation by stimulating PDE5 expression, which further degrades cGMP. Both Cycloporine and sildenafil can suppress ET-l-sfimulated PASMC proliferation in vitro.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2013年第1期26-29,共4页 Journal of Southern Medical University
基金 国家自然科学基金(81070045) 卫生部部属(管)医院临床学科重点项目(111) 教育部高等学校博士学科点专项科研基金(20100201110050)~~
关键词 CALCINEURIN NFAT信号通路 5型磷酸二酯酶 内皮素-1 细胞增殖 肺动脉平滑肌细胞 calcineurin/NFAT signaling pathway phosphodiesterase-5 endothelin-1 cell proliferation pulmonary artery smooth muscle cells
  • 相关文献

参考文献23

  • 1Voelkel NF,Grossman C, Bogaard HJ. Pulmonary hypertensionassociated with chronic obstructive pulmonary diseases [M]//textbook of pulmonary vascular disease, New York: Springer, 2011:1189-96.
  • 2Wilkins M. Pulmonary hypertension: the science behind the diseasespectrum[J]. Eur Respir Rev, 2012, 21(123): 19-26.
  • 3Kim GH,Ryan JJ, Marsboom G, et al. Epigenetic mechanisms ofpulmonary hypertension[j]. Pulm Circ, 2011, 1(3): 347-8.
  • 4Klinger JR. Tadalafil for the treatment of pulmonary arterialhypertensionfj]. Expert Rev Respir Med, 2011, 5(3): 315-28.
  • 5Hu H, Zharikov S, Patel JM. Novel peptide for attenuation ofhypoxia-induced pulmonary hypertension via modulation of nitricoxide release and phosphodiesterase-5 activity [j]. Peptides, 2012,35(1): 78-85.
  • 6Galie N, Ghofrani HA, Torbicki A, et al. Sildenafil citrate therapyfor pulmonary arterial hypertension [J]. N Engl J Med, 2005, 353(20):2148-57.
  • 7Chan MC, Weisman AS, Kang H, et al. The amiloride derivativephenamil attenuates pulmonary vascular remodeling by activatingNFAT and the bone morphogenetic protein signaling pathway [J].Mol Cell Biol, 2011,31(3): 517-30.
  • 8Golovina VA, Blaustein MP. Preparation of primary cultured mesen-teric artery smooth muscle cells for fluorescent imaging and physio-logical studies[j]. Nat Protoc, 2006, 1(6): 2681-7.
  • 9Finsen AV,Lunde IG, Sjaastad I, et al. Syndecan-4 is essential fordevelopment of concentric myocardial hypertrophy via stretch-in-duced activation of the calcineurin-NFAT pathway [J]. PloS one,2011,6(12): 28302-7.
  • 10Hogan PG, Chen L, Nardone J, et al. Transcriptional regulation bycalcium, calcineurin, and NFAT [J]. Genes Dev, 2003,17(18):2205-32.

二级参考文献10

  • 1Xu Y,Stenmark KR,Das M,et al.Pulmonary artery smooth muscle cells from chronically hypoxic neonatal calves retain fetal-like and acquire new growth properties[J].Am J Physiol,1997,273:L234-45.
  • 2Dempsey EC,Das M,Frid MG,et al.Hypoxic growth of bovine pulmonary artery smooth muscle cells[J].Chest,1998,114:29S-30S.
  • 3Wang HL,Zhang XH,Jin X,et al.Tetrandrine inhibited chronic"inflammatory" pulmonary hypertension in rats[J].Acta Pharmacol Sin,1997,18(5):401-4.
  • 4Tsai BM,Wang M,Pitcher JM,et al.Hypoxic pulmonary vasoconstriction and pulmonary artery tissue cytokine expression are mediated by protein kinase C[J].Am J Physiol Lung Cell Mol Physiol,2004,287(6):L1215-9.
  • 5Zhao Y,Rhoades RA,Packer CS.Hypoxia induced pulmonary arterial contraction appears to be dependent on myosin light chain phosphorylation[J].Am J Physiol Lung Cell Mol Physiol,1996,271(15):L768-74.
  • 6Griffith SL,Rhoades RA,Packer CS.Pulmonary arterial smooth muscle contractility in hypoxia-induced pulmonary hypertension[J].J Appl Physiol,1994,77:406-14.
  • 7Haller H,Maasch C,Lindschau C,et al.Intracellular targeting and protein kinase C in vascular smooth muscle cells:specific effects of different membrane-bound receptors[J].Acta Physiol Scand,1998,164(4):599-609.
  • 8王钢,孔垂泽,杨涛,董旭,温强,李泽良,宗志红,于秉治,刘同才.膀胱癌组织中蛋白激酶C及其抑制物活性的研究[J].中华泌尿外科杂志,2001,22(3):148-150. 被引量:1
  • 9钟声,徐永,张珍祥.慢性缺氧大鼠肺动脉一氧化氮合酶与蛋白激酶C表达变化关系的免疫组织化学研究[J].中国组织化学与细胞化学杂志,2000,9(3):248-250. 被引量:3
  • 10周浩,陈少贤,王良兴,王群姬,何秋莎,范小芳.蛋白激酶C对慢性低氧大鼠肺动脉胶原表达的调控及灯盏花素的干预作用[J].中华结核和呼吸杂志,2002,25(6):347-351. 被引量:19

共引文献2

同被引文献87

  • 1阮凯丽,帅佳丽,黄国强,叶泽鑫.盐酸替罗非班用于急性心肌梗死介入治疗对左室射血分数、肌酸磷酸激酶同工酶的影响[J].血栓与止血学,2019,25(1):11-13. 被引量:11
  • 2赵建平,周志刚,胡红玲,郭治,汪涛,甄国华,张珍祥.低氧条件下大鼠肺动脉平滑肌细胞中活性氧与低氧诱导因子-1α和细胞增殖的关系(英文)[J].生理学报,2007,59(3):319-324. 被引量:10
  • 3Li M,Liu Y, Sun X, et al. Sildenafil inhibits calcineurin/ NFATc2-mediated cyclin A expression in pulmonary artery smooth muscle cells [J]. Life Sci,2011,89 (17-18) : 644-649.
  • 4Mam V ,Tanbe AF, Vitali SH, et al. Impaired vasoconstric- tion and nitric oxide-mediated relaxation in pulmonary ar- teries of hypoxia- and monocrotaline-induced pulmonary hypertensive rats[ J ]. J Pharmacol Exp Ther, 2010,332(2) : 455-462.
  • 5Rosenblum WD. Pulmonary arterial hypertension: patho- biology,diagnosis,treatment,and emerging therapies [J]. Cardiol Rev,2010, 18(2) :58-63.
  • 6Oka M, Homma N,Taraseviciene-Stewart L,et al. Rho ki- nase-mediated vasoconstriction is important in severe oc- clusive pulmonary arterial hypertension in rats [J]. Circ Res, 2007,100 (6) : 923 -929.
  • 7Firth AL, Yao W, Remillard CV, et al. Upregulation of Oct- 4 isoforms in pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension [J]. Am J Physiol Lung Cell Mol Physiol, 2010,298 (4) : L548-557.
  • 8Hanze J, Weissmann N, Grimminger F, et al. Cellular and molecular mechanisms of hypoxia-inducible factor driven vascular remodeling [J]. Thromb Haemost,2007,97(5): 774-787.
  • 9Stenmark KR, Fagan KA, Frid MG. Hypoxia-induced pul- monary vascular remodeling: cellular and molecular mechanisms[J]. Circ Res,2006,99(7):675-691.
  • 10Chan MC,Weisman AS,Kang H,et al. The amiloride derivative phenamil attenuates pulmonary vascular re- modeling by activating NFAT and the bone morphogenet- ic protein signaling pathway [J]. Mol Cell Biol,2011,31 (3) :517-530.

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部